Home/SEC 13D/G/RADXSEC 13D/GRADX - Radiopharm Theranostics Limited - SEC Filing Update (04-SEP-2026) | ThinkSabio - Stocks Simplified$RADX$2.08βΌ -59.69% YTDHealthcareSep 4, 2026 Β· ThinkSabio BlogSEC Filing Update: #RADX Radiopharm Theranostics Limited : $2.08 Sector: Healthcare | YTD: π½ -59.69% The SEC disclosed Today (04-SEP-2026) that LANTHEUS HOLDINGS, INC. has Newly bought 792,958,513 #RADX shares Ownership: 20.9% * Estimated Investment Value: $1.79B https://www.thinksabio.com/reports/isr/RADX Institutional ownership in #RADX has been steadily rising over the past 2 quarters in Shares: Q1 2026: 51.31M Q2 2026: 102.13M π Stay ahead of institutional buy/sell moves β Sign up free at ThinkSabio: Sign Up Free β π¦ See this update on X: https://x.com/Thinksabio/status/2095979200079405543 Lantheus Holdings, Inc. acquired 792,958,513 shares of Radx, increasing its ownership stake to 20.9% from a previous position of 0 shares. Share this postπCopy Linkπ¬ Comments Loading commentsβ¦Leave a commentPost Commentβ All PostsMore SEC 13D/G